UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (7), p.980-988

2018

Volltextzugriff (PDF)

Interferon‐free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.139-149

2017

Volltextzugriff (PDF)

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

Alimentary pharmacology & therapeutics, 2018-08, Vol.48 (4), p.451-459

2018

Volltextzugriff (PDF)

A Prospective Evaluation of Pulmonary, Systemic and Hepatic Haemodynamics in HIV–HCV-Coinfected Patients before and after Antiviral Therapy with Pegylated Interferon and Ribavirin

Antiviral therapy, 2012-01, Vol.17 (7), p.1327-1334

2012

Volltextzugriff (PDF)

Non-selective [beta]-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis

Journal of gastroenterology, 2012-05, Vol.47 (5), p.561

2012

Volltextzugriff (PDF)

The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis

Hepatology communications, 2022-05, Vol.6 (5), p.950-964

Reiberger, Thomas

2022

Volltextzugriff (PDF)

Beta adrenergic blockade and decompensated cirrhosis

Journal of hepatology, 2017-04, Vol.66 (4), p.849-859

2017

Volltextzugriff (PDF)

Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes

PloS one, 2023-08, Vol.18 (8), p.e0290352-e0290352

2023

Volltextzugriff (PDF)

The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis

Journal of gastroenterology, 2020-05, Vol.55 (5), p.533-542

2020

Volltextzugriff (PDF)

Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosis

Liver international, 2023-10, Vol.43 (10), p.2220-2231

2023

Volltextzugriff (PDF)

Carvedilol as the new non‐selective beta‐blocker of choice in patients with cirrhosis and portal hypertension

Liver international, 2023-06, Vol.43 (6), p.1183-1194

2023

Volltextzugriff (PDF)

Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update

Cells (Basel, Switzerland), 2022-11, Vol.11 (22), p.3531

2022

Volltextzugriff (PDF)

Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality

Journal of hepatology, 2021-04, Vol.74 (4), p.819-828

2021

Volltextzugriff (PDF)

The rationale and study design of two phase II trials examining the effects of BI 685509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosis

Trials, 2023-12, Vol.24 (1), p.1-17, Article 293

2023

Volltextzugriff (PDF)

Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder

European radiology, 2023-02, Vol.33 (2), p.1422-1432

2023

Volltextzugriff (PDF)

The systemic and hepatic alternative renin-angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation

Scientific reports, 2023-01, Vol.13 (1), p.953-953, Article 953

2023

Volltextzugriff (PDF)

Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes

Gut, 2021-09, Vol.70 (9), p.1758-1767

2021

Volltextzugriff (PDF)

The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

Journal of hepatology, 2020-10, Vol.73 (4), p.842-854

2020

Volltextzugriff (PDF)

Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease

The American journal of gastroenterology, 2021-04, Vol.116 (4), p.723-732

2021

Volltextzugriff (PDF)

Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis

Journal of gastroenterology, 2022-02, Vol.57 (2), p.99-110

2022

Volltextzugriff (PDF)

Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasion

Cancer imaging, 2024-01, Vol.24 (1), p.9-9, Article 9

2024

Volltextzugriff (PDF)

Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease

Liver international, 2020-01, Vol.40 (1), p.194-204

2020

Volltextzugriff (PDF)

The impact of hepatic steatosis on portal hypertension

PloS one, 2019-11, Vol.14 (11), p.e0224506-e0224506

2019

Volltextzugriff (PDF)

Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis

Hepatology (Baltimore, Md.), 2012-10, Vol.56 (4), p.1439-1447

2012

Volltextzugriff (PDF)

Portal hypertension and its prognostic implications in patients with Wilson's disease

Alimentary pharmacology & therapeutics, 2024-07, Vol.60 (2), p.257-266

2024

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Aktive Filter

ThemaHypertension

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(60)

Sprache

Englisch
(60)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity

Interferon‐free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

A Prospective Evaluation of Pulmonary, Systemic and Hepatic Haemodynamics in HIV–HCV-Coinfected Patients before and after Antiviral Therapy with Pegylated Interferon and Ribavirin

Non-selective [beta]-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis

The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis

Beta adrenergic blockade and decompensated cirrhosis

Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes

The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis

Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosis

Carvedilol as the new non‐selective beta‐blocker of choice in patients with cirrhosis and portal hypertension

Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update

Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality

The rationale and study design of two phase II trials examining the effects of BI 685509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosis

Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder

The systemic and hepatic alternative renin-angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation

Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes

The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease

Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis

Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasion

Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease

The impact of hepatic steatosis on portal hypertension

Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis

Portal hypertension and its prognostic implications in patients with Wilson's disease

Aktive Filter

Suchergebnisse filtern